Maintaining Renin-Angiotensin-Aldosterone System Inhibitor Treatment with Patiromer in Hyperkalaemic Chronic Kidney Disease Patients: Comparison of a Propensity-Matched Real-World Population with AMETHYST-DN.

Chinnadurai, Rajkumar; Rengarajan, Sharmilee; Budden, Jeffrey J; Quinn, Carol Moreno; Kalra, Philip A

Chinnadurai, Rajkumar; Rengarajan, Sharmilee; Budden, Jeffrey J; Quinn, Carol Moreno; Kalra, Philip A.

Affiliation

Chinnadurai R; Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, UK.
Rengarajan S; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
Budden JJ; Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, UK.
Quinn CM; CSL Vifor, Redwood City, California, USA.
Kalra PA; CSL Vifor, Glattbrugg, Switzerland.

Am J Nephrol ; 54(9-10): 408-415, 2023.

Article in En | MEDLINE | ID: mdl-37725919

Subject(s)

Diabetes Mellitus, Type 2; Heart Failure; Hyperkalemia; Renal Insufficiency, Chronic; Adult; Humans; Aldosterone; Angiotensin-Converting Enzyme Inhibitors/adverse effects; Antihypertensive Agents/therapeutic use; Diabetes Mellitus, Type 2/drug therapy; Enzyme Inhibitors/therapeutic use; Hyperkalemia/drug therapy; Hyperkalemia/etiology; Potassium; Prospective Studies; Renin-Angiotensin System

Key words

Chronic kidney disease; Hyperkalaemia; Patiromer; Renin-angiotensin-aldosterone system inhibitors; Type 2 diabetes mellitus

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Renal Insufficiency, Chronic / Heart Failure / Hyperkalemia Type of study: Clinical_trials / Guideline Limits: Adult / Humans Language: En Journal: Am J Nephrol Year: 2023 Document type: Article Affiliation country: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google